HR23B, a biomarker for HDAC inhibitors

HR23B, a biomarker for HDAC inhibitors

<p>As our understanding of cancer biology increases and novel therapies are developed, an increasing number of predictive biomarkers are becoming clinically available. Aberrant acetylation has been strongly linked to tumourigenesis and the modulation of acetylation through targeting histone d...

Полное описание

Библиографические подробности
Главный автор:	Khan, OA
Другие авторы:	La Thangue, NB
Формат:	Диссертация
Язык:	English
Опубликовано:	2013
Предметы:	Pharmacology Tumours Clinical laboratory sciences Medical Sciences Oncology

Схожие документы

Mitochondrial modulators of hypoxia-related pathways in tumours
по: Snell, CE
Опубликовано: (2013)

Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment
по: New, M
Опубликовано: (2014)

Angiogenesis in human lung tumours
по: Ferguson, ML
Опубликовано: (2008)

Risk factors for haemorrhage in patients with haematological malignancies
по: Estcourt, LJ
Опубликовано: (2014)

Regulation of stemness and differentiation in colorectal cancer
по: Gandhi, S
Опубликовано: (2010)

Development of sindbis virus as an oncolytic agent
по: Kueberuwa, GLB
Опубликовано: (2012)

Tumour-stroma interaction in pancreatic cancer
по: Lunardi, S
Опубликовано: (2013)

Targeting EGFR signalling pathway in triple negative breast cancer
по: Albukhari, A
Опубликовано: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
по: Albukhari, A
Опубликовано: (2014)

Characterising the role of circulating immune cells in brain metastasis
по: Balathasan, L
Опубликовано: (2012)

The role of ATF4 in hypoxia-induced cell death in cancer
по: Pike, L, и др.
Опубликовано: (2011)

Combining regulatory angiogenic gene therapy and virotherapy for the treatment of breast cancer
по: Bazan Peregrino, M
Опубликовано: (2007)

Modulating the immune system by amino acid depletion - IDO and beyond
по: Vallius, L
Опубликовано: (2011)

Novel signalling pathways regulating epithelial-mesenchymal transition in bone metastatic prostate cancer
по: Rao, SR
Опубликовано: (2014)

Arginine methylation in the E2F1 pathway
по: Zheng, S
Опубликовано: (2013)

Investigating a role of ASPP2 in the cellular response to infection
по: Lim, Y, и др.
Опубликовано: (2014)

Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
по: Potter, M
Опубликовано: (2014)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
по: Thoma, CMM
Опубликовано: (2011)

HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.
по: Khan, O, и др.
Опубликовано: (2010)

The role of host microenvironment in the pathogenesis of multiple myeloma
по: Lwin, STS
Опубликовано: (2014)

Targeting polymer coated adenovirus to tumour-associated vasculature
по: Bachtarzi, H
Опубликовано: (2010)

Managing melanoma in the era of personalised therapy: more than one disease
по: Rughani, M, и др.
Опубликовано: (2012)

Loss of chaperone protein in human cancer
по: Adighibe, O
Опубликовано: (2012)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
по: Wijeyekoon, JB
Опубликовано: (2013)

Tolerance in renal transplantation: is mixed chimerism the missing link?
по: Janes, S, и др.
Опубликовано: (2009)

The role of DLL4-NOTCH signalling in endothelial cell metabolism
по: Harjes, U
Опубликовано: (2014)

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
по: Jackson, M
Опубликовано: (2013)

The role of HER4 in relation to trastuzumab resistance and prognosis in HER2 positive breast cancer
по: Mohd Nafi, SN
Опубликовано: (2014)

Development of clinical biomarkers of DNA double strand breaks for cancer care
по: Shah, K
Опубликовано: (2012)

Biomarkers of anti-angiogenic therapy in breast cancer
по: Mehta, S
Опубликовано: (2014)

Development of bioreductive inhibitors of checkpoint kinase 1 to target hypoxic tumours
по: Körner, C
Опубликовано: (2015)

Selective targeting of homologous recombination deficiency
по: Zimmer, J
Опубликовано: (2014)

The three methyls: the function and therapeutic potential of histone H3K36 trimethylation
по: Pfister, SX
Опубликовано: (2014)

Impact of TMPRSS2-ERG fusion gene on prostate cancer cell response to chemotherapy, radiotherapy and androgen deprivation therapy
по: Ovtcharov, S
Опубликовано: (2015)

Targeting cell adhesion as a method of sensitising metastatic tumour cells to TRAIL-induced apoptosis
по: Phipps, L
Опубликовано: (2011)

Cortical dynamics subserving visual apparent motion
по: Ahmed, B, и др.
Опубликовано: (2008)

Investigating the endogenous role of human n-acetyltransferase 1, as potential breast cancer biomarker, using chemical biology
по: Laurieri, N
Опубликовано: (2012)

Heterogeneity of tumour response to hypoxia: carbonic anhydrase IX induction defines a subpopulation of hypoxic cells with stem cell properties and drug resistance
по: Ledaki, I
Опубликовано: (2013)

A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.
по: New, M, и др.
Опубликовано: (2013)

A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
по: New, M, и др.
Опубликовано: (2013)